Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer

June 17, 2026 6:03 AM

Oppenheimer analyst Jeff Jones lowered the price target on Corbus Pharmaceuticals (NASDAQ: CRBP) to $52.00 (from $54.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found